Jazz, AbCellera strike TCE discovery and development deal worth up to $792M per drug Read more →
'Biopharma ecosystem is back to full health,' fueled by M&A: PwC Read more →
Amenable FDA review bodes well for Moderna's mRNA flu shot ahead of adcomm grilling Read more →
« All Events
February 4, 2025 @ 11:30 am
Presentations from the Olink team on the value of combining genomic and proteomic data for the best insights into human disease and development of new therapeutics, and more. After, enjoy lunch and networking.